Photo from ASCO/X
Jun 27, 2024, 15:26
Diwakar Davar and Jason Luke discuss high-risk melanoma from the NADINA trial
The American Society of Clinical Oncology (ASCO) shared on X:
“Diwakar Davar and Jason Luke of UPMC Hillman Cancer Center discuss exciting advances in high-risk melanoma from the NADINA trial and other emerging approaches in immunotherapy from ASCO24 on the ASCO Daily News Podcast.”
Source: ASCO/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 2, 2025, 18:07
Jun 2, 2025, 18:00
Jun 2, 2025, 17:43
Jun 2, 2025, 17:18
Jun 2, 2025, 17:06
Jun 2, 2025, 15:40
Jun 2, 2025, 15:37
Jun 2, 2025, 15:20